色素-话题@MedSci

#色素#

654篇内容 | 6179人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680737, encodeId=5e171680e37f0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗, objectType=article, longId=213744, objectId=3257213e448e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3257213e448e, replyNumber=0, likeNumber=83, createdTime=2022-06-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3257213e448e, moduleTitle=罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3257213e448e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680774, encodeId=f2e91680e74a5, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=AJCD:外用维甲酸对色素性皮肤患者痤疮和炎症后色素沉着的影响, objectType=article, longId=220617, objectId=ccc022061eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccc022061eaf, replyNumber=0, likeNumber=83, createdTime=2022-07-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccc022061eaf, moduleTitle=AJCD:外用维甲酸对色素性皮肤患者痤疮和炎症后色素沉着的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccc022061eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680786, encodeId=ab4d1680e8662, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Eur J Cancer：监测黑色素瘤高危患者：卷积神经网络能否取代序贯数字皮肤镜检查策略？, objectType=article, longId=300572, objectId=9b0b3005e282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0b3005e282, replyNumber=0, likeNumber=97, createdTime=2022-07-25, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0b3005e282, moduleTitle=Eur J Cancer：监测黑色素瘤高危患者：卷积神经网络能否取代序贯数字皮肤镜检查策略？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0b3005e282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680803, encodeId=a5c116808034b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JGH:长期使用硫嘌呤不会增加炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险, objectType=article, longId=726395, objectId=f5b7e2639539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5b7e2639539, replyNumber=0, likeNumber=60, createdTime=2022-12-13, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5b7e2639539, moduleTitle=JGH:长期使用硫嘌呤不会增加炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5b7e2639539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680785, encodeId=93d51680e85fb, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Immunother Cancer：Toripalimab（特瑞普利单抗）联合axitinib（阿昔替尼）治疗转移性粘膜黑色素瘤的3年生存更新结果, objectType=article, longId=299734, objectId=92ab299e343d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92ab299e343d, replyNumber=0, likeNumber=96, createdTime=2022-05-27, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92ab299e343d, moduleTitle=J Immunother Cancer：Toripalimab（特瑞普利单抗）联合axitinib（阿昔替尼）治疗转移性粘膜黑色素瘤的3年生存更新结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92ab299e343d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680760, encodeId=74a71680e603b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=亚盛医药alrizomadlin（APG-115）治疗黑色素瘤获美国FDA快速通道资格, objectType=article, longId=217535, objectId=f52621e5352b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f52621e5352b, replyNumber=0, likeNumber=102, createdTime=2022-05-13, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f52621e5352b, moduleTitle=亚盛医药alrizomadlin（APG-115）治疗黑色素瘤获美国FDA快速通道资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f52621e5352b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680802, encodeId=e729168080221, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Comput Intell Neurosci：PRP治疗可有效且安全的改善黄褐斑的色素沉着, objectType=article, longId=726213, objectId=f924e26213eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f924e26213eb, replyNumber=0, likeNumber=98, createdTime=2022-07-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f924e26213eb, moduleTitle=Comput Intell Neurosci：PRP治疗可有效且安全的改善黄褐斑的色素沉着, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f924e26213eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680777, encodeId=5a511680e77fb, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2021CSCO专家采访黑色素瘤前言进展和热点话题, objectType=article, longId=221255, objectId=121d22125520, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121d22125520, replyNumber=0, likeNumber=53, createdTime=2022-07-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121d22125520, moduleTitle=2021CSCO专家采访黑色素瘤前言进展和热点话题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=121d22125520)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680751, encodeId=72c41680e517c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Br J Cancer：血浆ctDNA检测转移性黑色素瘤患者的临床进展分析, objectType=article, longId=215870, objectId=7c302158e0f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c302158e0f8, replyNumber=0, likeNumber=86, createdTime=2021-10-07, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c302158e0f8, moduleTitle=Br J Cancer：血浆ctDNA检测转移性黑色素瘤患者的临床进展分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c302158e0f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680832, encodeId=7297168083204, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=常见不典型病例赏析--髋关节色素绒毛结节性滑膜炎（摘自华夏周一读片）, objectType=article, longId=245508, objectId=ec93245508ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec93245508ff, replyNumber=0, likeNumber=0, createdTime=2022-01-14, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec93245508ff, moduleTitle=常见不典型病例赏析--髋关节色素绒毛结节性滑膜炎（摘自华夏周一读片）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec93245508ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680781, encodeId=7b401680e8142, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：未经治疗晚期黑色素瘤患者该采用瑞拉利单抗-纳武单抗组合治疗还是单独纳武单抗治疗？, objectType=article, longId=293533, objectId=069e293533fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=069e293533fd, replyNumber=0, likeNumber=67, createdTime=2022-02-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=069e293533fd, moduleTitle=NEJM：未经治疗晚期黑色素瘤患者该采用瑞拉利单抗-纳武单抗组合治疗还是单独纳武单抗治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=069e293533fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680749, encodeId=fac41680e49bb, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Cancer Res：早早使用大剂量激素管理irAE与抗PD-1单药治疗晚期黑色素瘤的预后不良相关, objectType=article, longId=215687, objectId=dd9b21568e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd9b21568e2a, replyNumber=0, likeNumber=55, createdTime=2021-12-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd9b21568e2a, moduleTitle=Clin Cancer Res：早早使用大剂量激素管理irAE与抗PD-1单药治疗晚期黑色素瘤的预后不良相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd9b21568e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680723, encodeId=fdaa1680e23a8, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：派姆单抗辅助治疗可显著提高晚期高危黑色素瘤的长期无远处复发存活率！, objectType=article, longId=209912, objectId=e3e920991243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3e920991243, replyNumber=0, likeNumber=62, createdTime=2021-04-15, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3e920991243, moduleTitle=Lancet Oncol：派姆单抗辅助治疗可显著提高晚期高危黑色素瘤的长期无远处复发存活率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3e920991243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680768, encodeId=4f261680e68ef, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Thyroid：甲状腺激素受体α基因的胚系突变易导致出现皮肤标记和黑色素细胞痣。, objectType=article, longId=219039, objectId=ead221903917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ead221903917, replyNumber=0, likeNumber=108, createdTime=2022-07-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ead221903917, moduleTitle=Thyroid：甲状腺激素受体α基因的胚系突变易导致出现皮肤标记和黑色素细胞痣。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ead221903917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680740, encodeId=eb501680e40c8, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Neurology-帕金森病，神经黑色素病变，影响运动or认知能力，解剖位置是重点！, objectType=article, longId=214079, objectId=c9242140e90a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9242140e90a, replyNumber=0, likeNumber=140, createdTime=2021-12-25, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9242140e90a, moduleTitle=Neurology-帕金森病，神经黑色素病变，影响运动or认知能力，解剖位置是重点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9242140e90a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680763, encodeId=dff11680e6336, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Eur J Cancer：使用派姆单抗治疗的晚期黑色素瘤患者的长期结局, objectType=article, longId=218034, objectId=095b21803441, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=095b21803441, replyNumber=0, likeNumber=71, createdTime=2022-03-23, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=095b21803441, moduleTitle=Eur J Cancer：使用派姆单抗治疗的晚期黑色素瘤患者的长期结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=095b21803441)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680765, encodeId=a3c51680e653f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Nat Med：新辅助T-VEC联合手术对可切除的IIIB-IVM1a期黑色素瘤患者的疗效分析, objectType=article, longId=218211, objectId=4e7c218211d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e7c218211d8, replyNumber=0, likeNumber=56, createdTime=2022-03-06, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e7c218211d8, moduleTitle=Nat Med：新辅助T-VEC联合手术对可切除的IIIB-IVM1a期黑色素瘤患者的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e7c218211d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680739, encodeId=a0ff1680e394c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=小儿黑色素瘤不是一种疾病，而是多种疾病！, objectType=article, longId=213886, objectId=ccc1213886d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccc1213886d8, replyNumber=0, likeNumber=78, createdTime=2022-04-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccc1213886d8, moduleTitle=小儿黑色素瘤不是一种疾病，而是多种疾病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccc1213886d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680736, encodeId=f9cb1680e360a, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Br J Cancer：Migrastatic：转移性黑色素瘤的潜在抗转移治疗药物, objectType=article, longId=213534, objectId=bbe3213534a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbe3213534a2, replyNumber=0, likeNumber=50, createdTime=2022-02-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbe3213534a2, moduleTitle=Br J Cancer：Migrastatic：转移性黑色素瘤的潜在抗转移治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbe3213534a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680780, encodeId=f9871680e801b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NICE推荐pembrolizumab单药作为3期黑色素瘤的辅助疗法, objectType=article, longId=292248, objectId=3be42922488a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be42922488a, replyNumber=0, likeNumber=69, createdTime=2022-09-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be42922488a, moduleTitle=NICE推荐pembrolizumab单药作为3期黑色素瘤的辅助疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be42922488a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗

2022-06-01

sunylz (审核中...)

前往app查看评论内容

#色素#

AJCD:外用维甲酸对色素性皮肤患者痤疮和炎症后色素沉着的影响

2022-07-09

sunylz (审核中...)

前往app查看评论内容

#色素#

Eur J Cancer：监测黑色素瘤高危患者：卷积神经网络能否取代序贯数字皮肤镜检查策略？

2022-07-25

sunylz (审核中...)

前往app查看评论内容

#色素#

JGH:长期使用硫嘌呤不会增加炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险

2022-12-13

sunylz (审核中...)

前往app查看评论内容

#色素#

J Immunother Cancer：Toripalimab（特瑞普利单抗）联合axitinib（阿昔替尼）治疗转移性粘膜黑色素瘤的3年生存更新结果

2022-05-27

sunylz (审核中...)

前往app查看评论内容

#色素#

亚盛医药alrizomadlin（APG-115）治疗黑色素瘤获美国FDA快速通道资格

2022-05-13

sunylz (审核中...)

前往app查看评论内容

#色素#

Comput Intell Neurosci：PRP治疗可有效且安全的改善黄褐斑的色素沉着

2022-07-05

sunylz (审核中...)

前往app查看评论内容

#色素#

2021CSCO专家采访黑色素瘤前言进展和热点话题

2022-07-08

sunylz (审核中...)

前往app查看评论内容

#色素#

Br J Cancer：血浆ctDNA检测转移性黑色素瘤患者的临床进展分析

2021-10-07

sunylz (审核中...)

前往app查看评论内容

#色素#

常见不典型病例赏析--髋关节色素绒毛结节性滑膜炎（摘自华夏周一读片）

2022-01-14

仁者大医 (审核中...)

前往app查看评论内容

#色素#

NEJM：未经治疗晚期黑色素瘤患者该采用瑞拉利单抗-纳武单抗组合治疗还是单独纳武单抗治疗？

2022-02-01

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Cancer Res：早早使用大剂量激素管理irAE与抗PD-1单药治疗晚期黑色素瘤的预后不良相关

2021-12-21

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：派姆单抗辅助治疗可显著提高晚期高危黑色素瘤的长期无远处复发存活率！

2021-04-15

sunylz (审核中...)

前往app查看评论内容

#色素#

Thyroid：甲状腺激素受体α基因的胚系突变易导致出现皮肤标记和黑色素细胞痣。

2022-07-10

sunylz (审核中...)

前往app查看评论内容

#色素#

Neurology-帕金森病，神经黑色素病变，影响运动or认知能力，解剖位置是重点！

2021-12-25

sunylz (审核中...)

前往app查看评论内容

#色素#

Eur J Cancer：使用派姆单抗治疗的晚期黑色素瘤患者的长期结局

2022-03-23

柳叶一刀 (审核中...)

前往app查看评论内容

#色素#

Nat Med：新辅助T-VEC联合手术对可切除的IIIB-IVM1a期黑色素瘤患者的疗效分析

2022-03-06

sunylz (审核中...)

前往app查看评论内容

#色素#

小儿黑色素瘤不是一种疾病，而是多种疾病！

2022-04-22

sunylz (审核中...)

前往app查看评论内容

#色素#

Br J Cancer：Migrastatic：转移性黑色素瘤的潜在抗转移治疗药物

2022-02-16

sunylz (审核中...)

前往app查看评论内容

#色素#

NICE推荐pembrolizumab单药作为3期黑色素瘤的辅助疗法

2022-09-16

科室
- - 订阅+
  - 更多科室
工具
服务